Biotech stocks make waves as products gain recognition
Nerve regeneration company Orthocell (ASX: OCC) is one of two Australian biotech to announce good news in the past week. The Perth company reported positive interim clinical results for CelGro, its collagen-based structure used as a scaffold to help rebuild damaged peripheral nerves. Orthocell’s CelGro achieved positive results in studies of 12 patients at St…